|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Aegerion Pharmaceuticals, Inc. (AEGR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
31,480,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.97 - $1.97 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Edelman Joseph |
10% Owner |
|
2012-10-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,594,733 |
|
- |
|
Edelman Joseph |
10% Owner |
|
2012-10-19 |
4 |
OE |
$17.50 |
$4,331,250 |
I/I |
247,500 |
2,347,233 |
|
- |
|
Peyromaure De Bord Alison |
10% Owner |
|
2012-10-16 |
4 |
S |
$18.67 |
$219,765 |
I/I |
(11,771) |
56,190 |
|
- |
|
Peyromaure De Bord Alison |
10% Owner |
|
2012-10-16 |
4 |
S |
$18.67 |
$2,394,035 |
D/D |
(128,229) |
2,280,197 |
|
- |
|
Peyromaure De Bord Alison |
10% Owner |
|
2012-10-15 |
4 |
S |
$17.54 |
$89,577 |
I/I |
(5,107) |
59,350 |
|
- |
|
Peyromaure De Bord Alison |
10% Owner |
|
2012-10-15 |
4 |
S |
$17.54 |
$975,680 |
D/D |
(55,626) |
2,408,426 |
|
- |
|
Rothera Mark |
Global PresidentOfficer |
|
2012-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,813 |
|
- |
|
Carter Martha J |
Chief Regulatory Officer |
|
2012-03-30 |
4 |
B |
$14.03 |
$14,030 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
Beer Marc D |
Chief Executive Officer |
|
2012-03-29 |
4 |
B |
$13.74 |
$13,735 |
D/D |
1,000 |
199,061 |
2.81 |
- |
|
Fitzpatrick Mark J. |
Chief Financial Officer |
|
2012-03-23 |
4 |
B |
$14.15 |
$7,076 |
D/D |
500 |
500 |
2.74 |
- |
|
Beer Marc D |
Chief Executive Officer |
|
2012-03-22 |
4 |
B |
$13.96 |
$13,964 |
D/D |
1,000 |
198,061 |
2.81 |
- |
|
Advent International Corp |
Member of Group > 10% |
|
2012-03-09 |
4 |
S |
$15.87 |
$1,586,830 |
I/I |
(100,000) |
2,457,879 |
|
- |
|
Advent International Llc |
Member of Group > 10% |
|
2012-03-09 |
4 |
S |
$15.87 |
$1,569,327 |
I/I |
(98,897) |
2,430,765 |
|
- |
|
Advent Healthcare & Life Sciences Iii Limited Part |
Member of Group > 10% |
|
2012-03-09 |
4 |
S |
$15.87 |
$635,954 |
D/D |
(40,077) |
985,052 |
|
- |
|
Ahls Iii Gp Limited Partnership |
Member of Group > 10% |
|
2012-03-09 |
4 |
S |
$15.87 |
$1,569,327 |
I/I |
(98,897) |
2,430,765 |
|
- |
|
Advent Partners Hls Iii Limited Partnership |
Member of Group > 10% |
|
2012-03-09 |
4 |
S |
$15.87 |
$17,503 |
D/D |
(1,103) |
27,114 |
|
- |
|
Advent Healthcare & Life Sciences Iii-A Limited Pa |
Member of Group > 10% |
|
2012-03-09 |
4 |
S |
$15.87 |
$933,373 |
D/D |
(58,820) |
1,445,713 |
|
- |
|
Advent International Llc |
Member of Group > 10% |
|
2012-01-31 |
4 |
S |
$17.10 |
$377,156 |
I/I |
(22,054) |
2,529,662 |
|
- |
|
Advent Partners Hls Iii Limited Partnership |
Member of Group > 10% |
|
2012-01-31 |
4 |
S |
$17.10 |
$4,207 |
D/D |
(246) |
28,217 |
|
- |
|
Advent Healthcare & Life Sciences Iii-A Limited Pa |
Member of Group > 10% |
|
2012-01-31 |
4 |
S |
$17.10 |
$224,320 |
D/D |
(13,117) |
1,504,533 |
|
- |
|
Advent Healthcare & Life Sciences Iii Limited Part |
Member of Group > 10% |
|
2012-01-31 |
4 |
S |
$17.10 |
$152,836 |
D/D |
(8,937) |
1,025,129 |
|
- |
|
Advent International Corp |
Member of Group > 10% |
|
2012-01-31 |
4 |
S |
$17.10 |
$381,363 |
I/I |
(22,300) |
2,557,879 |
|
- |
|
Ahls Iii Gp Limited Partnership |
Member of Group > 10% |
|
2012-01-31 |
4 |
S |
$17.10 |
$377,156 |
I/I |
(22,054) |
2,529,662 |
|
- |
|
Yucca Partners L.p. Jersey Branch |
10% Owner |
|
2012-01-30 |
4 |
S |
$17.08 |
$854,000 |
I/I |
(50,000) |
2,081,827 |
|
- |
|
Advent International Llc |
Member of Group > 10% |
|
2012-01-30 |
4 |
S |
$17.06 |
$45,563 |
I/I |
(2,670) |
2,551,716 |
|
- |
|
251 Records found
|
|
Page 6 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|